Details for Patent: 11,091,459

Which drugs does patent 11,091,459 protect, and when does it expire?

Patent 11,091,459 protects ZEJULA and AKEEGA and is included in three NDAs.

This patent has fifteen patent family members in thirteen countries.

Summary for Patent: 11,091,459

Title:	Niraparib compositions
Abstract:	The present invention relates to compositions comprising the compound niraparib, in particular certain solid forms of niraparib.
Inventor(s):	Wu; George (Waltham, MA), Chaber; John (Waltham, MA), McKeown; Arlene E. (Rahway, NJ), Foley; Jennifer R. (Rahway, NJ)
Assignee:	Tesaro, Inc. (Waltham, MA) Merck Sharp & Dohme Corp. (Rahway, NJ)
Application Number:	16/584,401
Patent Claim Types: see list of patent claims	Use; Composition; Compound; Dosage form;

Drugs Protected by US Patent 11,091,459

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Patented / Exclusive Use	Submissiondate
Glaxosmithkline	ZEJULA	niraparib tosylate	CAPSULE;ORAL	208447-001	Mar 27, 2017		DISCN	Yes	No			Y
Janssen Biotech	AKEEGA	abiraterone acetate; niraparib tosylate	TABLET;ORAL	216793-001	Aug 11, 2023		RX	Yes	No			Y	Y
Janssen Biotech	AKEEGA	abiraterone acetate; niraparib tosylate	TABLET;ORAL	216793-002	Aug 11, 2023		RX	Yes	Yes			Y	Y
Glaxosmithkline	ZEJULA	niraparib tosylate	TABLET;ORAL	214876-001	Apr 26, 2023		RX	Yes	No			Y

International Family Members for US Patent 11,091,459

Country	Patent Number	Estimated Expiration	Supplementary Protection Certificate	SPC Country	SPC Expiration
Australia	2018246214
Australia	2021245223
Brazil	112019020211
Canada	3058375